10810896 — Ocrelizumab 300 Mg/10 Ml Sol [Brod]
Cite this view
HANK Price Transparency. (n.d.). Ocrelizumab 300 Mg/10 Ml Sol [Brod] (CDM 10810896) negotiated rates. PPMan price-transparency data, derived from CMS-required hospital MRFs. Retrieved , from http://ppman.hank.ai/transparency/code/10810896?code_type=CDM
“Ocrelizumab 300 Mg/10 Ml Sol [Brod] (CDM 10810896) negotiated rates.” HANK Price Transparency, http://ppman.hank.ai/transparency/code/10810896?code_type=CDM. Accessed .
“Ocrelizumab 300 Mg/10 Ml Sol [Brod] (CDM 10810896) negotiated rates,” HANK Price Transparency, accessed , http://ppman.hank.ai/transparency/code/10810896?code_type=CDM.
Source: PPMan price-transparency data, derived from CMS-required hospital machine-readable files (45 CFR 180). See methodology.
Usually $55,062–$56,221 (25th–75th percentile) across 1 hospital · 6 payers.
“Negotiated” is the hospital’s negotiated facility rate for this CDM 10810896 — the consumer-grade median across the country. It covers the facility charge only; the surgeon’s and anesthesiologist’s fees are billed separately.
Per-month price trends are temporarily unavailable while we rebuild them on quality-filtered rates. The medians, percentiles, and per-hospital rates on this page are the quality-filtered figures.
Hospital rates (per row)
Showing consumer-grade rates only. Flagged / outlier filings (excluded from the medians above) are hidden — tick “Show flagged / outlier rates” to include them.
| Hospital | Payer | Plan | Negotiated rate | Gross | Cash | Observed | Source |
|---|---|---|---|---|---|---|---|
| BRODSTONE HEALTHCARE Both | Medica | Commercial | $52,744.00 | $57,960.00 | $55,062.00 | 2026-05-22 | MRF ↗ |
| BRODSTONE HEALTHCARE Both | Ambetter | Commercial | $55,062.00 | $57,960.00 | $55,062.00 | 2026-05-22 | MRF ↗ |
| BRODSTONE HEALTHCARE Both | Blue Cross Blue Shield of Nebraska | Commercial | $55,062.00 | $57,960.00 | $55,062.00 | 2026-05-22 | MRF ↗ |
| BRODSTONE HEALTHCARE Both | United Healthcare | Commercial | $56,221.00 | $57,960.00 | $55,062.00 | 2026-05-22 | MRF ↗ |
| BRODSTONE HEALTHCARE Both | Midlands Choice | Commercial | $56,221.00 | $57,960.00 | $55,062.00 | 2026-05-22 | MRF ↗ |
| BRODSTONE HEALTHCARE Both | Coventry Health Care | Commercial | $56,801.00 | $57,960.00 | $55,062.00 | 2026-05-22 | MRF ↗ |